Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 26 of 35
Post-traumatic Arthritis Associated With Joint Injury
NCT01792791
Time of Intravenous Acetaminophen Administration
NCT01699815
MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery
NCT01691742
Breakfast Nutrition and Inpatient Glycemia
NCT01805414
Measuring Eating, Activity and Strength: Understanding the Response -Using Protein
NCT01715753
Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
NCT01694420
Text Message Study
NCT01789697
Phenylephrine Versus Ephedrine in Pre-eclampsia
NCT02025426
Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP
NCT02297750
Randomized Controlled Trial of Trauma-focused CBT in Tanzania and Kenya
NCT01822366
Evaluating a Novel Method of Generalizing Emotion Regulation
NCT01653548
Palliative Care in Heart Failure
NCT01589601
Improving Biopsy Experiences Study for Women
NCT01811043
Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging
NCT01834196
Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias
NCT01730430
Oral Health Intervention Pilot Study for Individuals With Memory Problems
NCT01808235
Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery
NCT01646541
Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)
NCT01627288
Use of a Mobile-based App for SCD Patients
NCT01833702
Heart and Muscle Metabolism in Barth Syndrome
NCT01625663
Caloric Stimulation on Cerebral Blood Flow
NCT01629901
Nitrites, Exercise, and Peripheral Arterial Disease
NCT01684930
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
NCT02173561
Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes
NCT01786941
Albuterol in Individuals With Late Onset Pompe Disease (LOPD)
NCT01859624
Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects
NCT01788696
Exploring Massage Benefits for Arthritis of the Knee
NCT01537484
Clinical Evaluation of Direct Dorsal Column Stimulation
NCT02020460
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
NCT01748565
Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository
NCT01720472
Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
NCT01560507
Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator
NCT01576042
Once-Daily Asenapine for Schizophrenia
NCT01549041
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
NCT01579370
Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE)
NCT02028052
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
NCT01491594
Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
NCT01779323
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
NCT02006823
Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV
NCT01804907
Effect of Broccoli Sprouts Homogenate on SS RBC
NCT01715480
Comparison of Hand Feeding Techniques for Persons With Dementia
NCT01780402
Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia
NCT01640275
Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A
NCT01483209
A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care
NCT01725022
Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma
NCT01497275
Evaluation of DVD and Internet Decision Aids for Hip and Knee Osteoarthritis: Focus on Health Literacy
NCT01618097
Adaptive Pet Study
NCT01908504
The Effects of Antihistamines on Pre-Pulse Inhibition
NCT01537471
Caregiver Outlook: An Evidence-based Intervention for the Chaplain Toolkit
NCT01768221
Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
NCT01513746
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.